Atrial Fibrillation and Cognition: Epidemiological Data and Possible Mechanisms

Stroke

Volumn 46, Issue 11, 2015, Pages 3316-3321

  Poggesi, Anna ^a   Inzitari, Domenico ^a,b   Pantoni, Leonardo ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b CNR   (Italy)

Author keywords

atrial fibrillation; cognition; dementia; magnetic resonance imaging; stroke

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DEMENTIA; ELECTROCARDIOGRAPHY MONITORING; HUMAN; INCIDENCE; MENTAL DETERIORATION; NEUROIMAGING; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT INDICATION; COGNITION DISORDERS; PATHOPHYSIOLOGY; STROKE;

ATRIAL FIBRILLATION; COGNITION DISORDERS; DEMENTIA; HUMANS; RISK FACTORS; STROKE;

EID: 84946483842     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.008225     Document Type: Review

References (46)

1. Di Carlo A, Baldereschi M, Amaducci L, Lepore V, Bracco L, Maggi S, ILSA Working Group Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study. J Am Geriatr Soc 2002 50 41 48
2. Pantoni L, Poggesi A, Inzitari D, Cognitive decline and dementia related to cerebrovascular diseases: some evidence and concepts. Cerebrovasc Dis 2009 27(suppl 1) 191 196. doi: 10.1159/000200459
3. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014 64 e1 e76. doi: 10.1016/j.jacc.2014.03.022
4. [No authors listed]. Cardiogenic dementia. Lancet 1977 1 27 28
5. Mead GE, Keir S, Association between cognitive impairment and atrial fibrillation: a systematic review. J Stroke Cerebrovasc Dis 2001 10 35 43. doi: 10.1053/jscd.2001.24663
6. Kwok CS, Loke YK, Hale R, Potter JF, Myint PK, Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis. Neurology 2011 76 914 922. doi: 10.1212/WNL.0b013e31820f2e38
7. Santangeli P, Di Biase L, Bai R, Mohanty S, Pump A, Cereceda Brantes M, Atrial fibrillation and the risk of incident dementia: a meta-analysis. Heart Rhythm 2012 9 1761 1768. doi: 10.1016/j.hrthm.2012.07.026
8. Kalantarian S, Stern TA, Mansour M, Ruskin JN, Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med 2013 158 5 pt 1 338 346. doi: 10.7326/0003-4819-158-5-201303050-00007
9. Udompanich S, Lip GY, Apostolakis S, Lane DA, Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review. QJM 2013 106 795 802. doi: 10.1093/qjmed/hct129
10. Hui DS, Morley JE, Mikolajczak PC, Lee R, Atrial fibrillation: a major risk factor for cognitive decline. Am Heart J 2015 169 448 456. doi: 10.1016/j.ahj.2014.12.015
11. Jacobs V, Cutler MJ, Day JD, Bunch TJ, Atrial fibrillation and dementia. Trends Cardiovasc Med 2015 25 44 51. doi: 10.1016/j.tcm.2014.09.002
12. Lip GY, Lane DA, Stroke prevention in atrial fibrillation: a systematic review. JAMA 2015 313 1950 1962. doi: 10.1001/jama.2015.4369
13. Ratcliffe PJ, Wilcock GK, Cerebrovascular disease in dementia: the importance of atrial fibrillation. Postgrad Med J 1985 61 201 204
14. Dublin S, Anderson ML, Heckbert SR, Hubbard RA, Sonnen JA, Crane PK, Neuropathologic changes associated with atrial fibrillation in a population-based autopsy cohort. J Gerontol A Biol Sci Med Sci 2014 69 609 615. doi: 10.1093/gerona/glt141
15. Leys D, Hénon H, Mackowiak-Cordoliani MA, Pasquier F, Poststroke dementia. Lancet Neurol 2005 4 752 759. doi: 10.1016/S1474-4422(05)70221-0
16. Björck S, Palaszewski B, Friberg L, Bergfeldt L, Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study. Stroke 2013 44 3103 3108. doi: 10.1161/STROKEAHA.113.002329
17. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A, Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 1997 28 316 321
18. Thacker EL, McKnight B, Psaty BM, Longstreth WT Jr, Sitlani CM, Dublin S, Atrial fibrillation and cognitive decline: a longitudinal cohort study. Neurology 2013 81 119 125. doi: 10.1212/WNL.0b013e31829a33d1
19. Chen LY, Lopez FL, Gottesman RF, Huxley RR, Agarwal SK, Loehr L, Atrial fibrillation and cognitive decline-the role of subclinical cerebral infarcts: the atherosclerosis risk in communities study. Stroke 2014 45 2568 2574. doi: 10.1161/STROKEAHA.114.005243
20. Pantoni L, Not-so-silent infarcts. Lancet Neurol 2003 2 335
21. Lavy S, Stern S, Melamed E, Cooper G, Keren A, Levy P, Effect of chronic atrial fibrillation on regional cerebral blood flow. Stroke 1980 11 35 38
22. Ide K, Gulløv AL, Pott F, Van Lieshout JJ, Koefoed BG, Petersen P, Middle cerebral artery blood velocity during exercise in patients with atrial fibrillation. Clin Physiol 1999 19 284 289
23. Alosco ML, Spitznagel MB, Sweet LH, Josephson R, Hughes J, Gunstad J, Atrial fibrillation exacerbates cognitive dysfunction and cerebral perfusion in heart failure. Pacing Clin Electrophysiol 2015 38 178 186. doi: 10.1111/pace.12543
24. Efimova I, Efimova N, Chernov V, Popov S, Lishmanov Y, Ablation and pacing: improving brain perfusion and cognitive function in patients with atrial fibrillation and uncontrolled ventricular rates. Pacing Clin Electrophysiol 2012 35 320 326. doi: 10.1111/j.1540-8159.2011.03277.x
25. Watson T, Shantsila E, Lip GY, Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. Lancet 2009 373 155 166. doi: 10.1016/S0140-6736(09)60040-4
26. Vílchez JA, Roldán V, Hernández-Romero D, Valdés M, Lip GY, Marín F, Biomarkers in atrial fibrillation: an overview. Int J Clin Pract 2014 68 434 443. doi: 10.1111/ijcp.12304
27. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007 6 734 746. doi: 10.1016/S1474-4422(07)70178-3
28. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013 12 822 838. doi: 10.1016/S1474-4422(13)70124-8
29. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol 2014 13 614 629. doi: 10.1016/S1474-4422(14)70090-0
30. Grammas P, Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease. J Neuroinflammation 2011 8 26. doi: 10.1186/1742-2094-8-26
31. Pantoni L, Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010 9 689 701. doi: 10.1016/S1474-4422(10)70104-6
32. Wardlaw JM, Smith C, Dichgans M, Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 2013 12 483 497. doi: 10.1016/S1474-4422(13)70060-7
33. Poggesi A, Pasi M, Pescini F, Pantoni L, Inzitari D, Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: a review. J Cereb Blood Flow Metab. doi: 10.1038/jcbfm.2015.116. http://www.nature.com/jcbfm/journal/vaop/ncurrent/full/jcbfm2015116a.html. Accessed August 4, 2015
34. de Leeuw FE, de Groot JC, Oudkerk M, Kors JA, Hofman A, van Gijn J, Atrial fibrillation and the risk of cerebral white matter lesions. Neurology 2000 54 1795 1801
35. Valenti R, Pantoni L, Markus HS, Treatment of vascular risk factors in patients with a diagnosis of Alzheimer's disease: a systematic review. BMC Med 2014 12 160. doi: 10.1186/s12916-014-0160-z
36. Li JQ, Tan L, Wang HF, Tan MS, Tan L, Xu W, Risk factors for predicting progression from mild cognitive impairment to Alzheimer's disease: a systematic review and meta-analysis of cohort studies. J Neurol Neurosurg Psychiatry. doi: 10.1136/jnnp-2014-310095. http://jnnp.bmj.com/content/early/2015/05/22/jnnp-2014-310095.long. Accessed August 4, 2015
37. Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY, Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 2010 123 638 645.e4. doi: 10.1016/j.amjmed.2009.11.025
38. Tanislav C, Milde S, Schwartzkopff S, Sieweke N, Krämer HH, Juenemann M, Secondary stroke prevention in atrial fibrillation: a challenge in the clinical practice. BMC Neurol 2014 14 195. doi: 10.1186/s12883-014-0195-y
39. Mielke MM, Rosenberg PB, Tschanz J, Cook L, Corcoran C, Hayden KM, Vascular factors predict rate of progression in Alzheimer disease. Neurology 2007 69 1850 1858. doi: 10.1212/01.wnl.0000279520.59792.fe
40. Jacobs V, Woller SC, Stevens S, May HT, Bair TL, Anderson JL, Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia. Heart Rhythm 2014 11 2206 2213. doi: 10.1016/j.hrthm.2014.08.013
41. Haeusler KG, Wilson D, Fiebach JB, Kirchhof P, Werring DJ, Brain MRI to personalise atrial fibrillation therapy: current evidence and perspectives. Heart 2014 100 1408 1413. doi: 10.1136/heartjnl-2013-305151
42. Clinical Relevance Of Microbleeds In Stroke CROMIS-2 Study Web site. http://www.ucl.ac.uk/cromis-2. Accessed August 4, 2015
43. Bunch TJ, Crandall BG, Weiss JP, May HT, Bair TL, Osborn JS, Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol 2011 22 839 845. doi: 10.1111/j.1540-8167.2011.02035.x
44. Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, EMBRACE Investigators and Coordinators Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 2014 370 2467 2477. doi: 10.1056/NEJMoa1311376
45. Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, CRYSTAL AF Investigators Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014 370 2478 2486. doi: 10.1056/NEJMoa1313600
46. Rabinstein AA, Prolonged cardiac monitoring for detection of paroxysmal atrial fibrillation after cerebral ischemia. Stroke 2014 45 1208 1214. doi: 10.1161/STROKEAHA.113.003389